Strategies for Engineered Negligible Senescence, 2nd Conference

工程可忽略衰老的策略，第二次会议

• 批准号: 7000509
• 负责人: AUBREY D DE GREY
• 金额: $ 2.5万
• 依托单位: METHUSELAH FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-07-01 至 2005-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7000509
• 关键词: aging; cell senescence; gene therapy; meeting /conference /symposium; stem cell transplantation; tissue engineering

DESCRIPTION (provided by applicant): This conference will take place on September 7th through 11th 2005 at Queens' College, University of Cambridge, Cambridge, England. The participants will mainly be research scientists but are expected to include interested laypeople as well. The topics to be covered include a wide range of biomedical and biotechnological disciplines relevant to the eventual repair of age-related molecular and cellular damage in mammals, including stem cell therapy, nuclear transfer, somatic gene therapy and tissue engineering. The meeting will also cover innovative ways in which such technologies may be employed in the foreseeable future in the repair or obviation of age-related changed currently immutable or only modestly retardable by known interventions, such as mitochondria! mutations, lysosomal and extracellular aggregates, protein-protein crosslinks, sarcopenia, visceral adiposity and tumors. This combination of topics is not adequately combined in other conferences, but it is an essential mix for those concerned with the long-term prospects for major intervention in the aging process, which (as all gerontologists know) is the single biggest contributor to frailty and debilitation throughout the developed world. In demonstration of this, the precursor of this conference (held at the same venue in September 2003) was exceptionally successful. The upcoming meeting has been able to build on the reputation of the 2003 meeting and has already attracted a host of illustrious confirmed speakers.

描述（由申请人提供）：本次会议将于2005年9月7日至11日在英国剑桥大学剑桥大学皇后学院举行。参与者将主要是研究科学家，但也有望包括有兴趣的外行人。要涵盖的主题包括广泛的生物医学和生物技术学科，与哺乳动物中最终修复与年龄相关的分子和细胞损伤有关，包括干细胞疗法，核转移，体细胞基因治疗和组织工程。该会议还将涵盖在可预见的未来可以在可预见的未来使用或消除与年龄相关的变化的创新方式，目前不可变化或仅通过已知干预措施（例如线粒体）不断变化！突变，溶酶体和细胞外聚集体，蛋白质 - 蛋白质交联，肌肉减少症，内脏肥胖和肿瘤。这种主题的结合在其他会议中没有足够的结合，但是对于那些与长期干预衰老过程的长期前景的人来说，这是一个重要的组合，这（众所周知学家都知道）是整个发达国家的脆弱和虚弱的唯一贡献者。为此，本次会议的先驱（2003年9月在同一地点举行）非常成功。即将举行的会议能够以2003年会议的声誉为基础，并且已经吸引了许多杰出的确认演讲者。